CD8A and cancer: As previously reported, gp96 participates in the regulation of immune evasion and surveillance during cancer progression (9), and CD8+ T is considered as the main immune cells to eliminate malignant cells by recognizing tumor-associated antigens in tumor cells (35, 36).